Biotech · Private company · Indianapolis, IN, US
Degrome Therapeutics, Inc.
Track this companyFree. Adds Degrome Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Development of Small-Molecule Degraders of APP as the first-in-class drugs for Alzheimer's therapyFiscal year 2024 · $499.9KNIH RePORTER 1R41AG090241-01 · fetched Nov 12, 2026